Cupertino, CA, United States of America

John L Stauffer

USPTO Granted Patents = 3 


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: John L Stauffer: Innovator in Pulmonary Fibrosis Treatment

Introduction

John L Stauffer is a notable inventor based in Cupertino, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of idiopathic pulmonary fibrosis (IPF). With a total of 3 patents, Stauffer's work has the potential to impact many lives.

Latest Patents

Stauffer's latest patents focus on innovative methods for treating idiopathic pulmonary fibrosis. The first patent describes methods and medicaments useful for treating IPF by administering anti-CTGF antibodies. Additionally, it provides methods for prognosing individuals with IPF. This groundbreaking approach aims to improve the quality of life for those affected by this challenging condition.

Career Highlights

Stauffer is currently associated with Fibrogen, Inc., a company dedicated to developing innovative therapies for serious diseases. His work at Fibrogen has allowed him to collaborate with other experts in the field and contribute to advancements in medical treatments.

Collaborations

One of his notable coworkers is Seth Porter, with whom he has likely shared insights and expertise in their research endeavors.

Conclusion

John L Stauffer's contributions to the treatment of idiopathic pulmonary fibrosis exemplify the impact of innovation in medicine. His patents and work at Fibrogen, Inc. highlight the importance of research and collaboration in developing effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…